Valuation: Alcon Inc.

Market Cap 35.89B 187B 31B 29.17B 26.51B 49.86B 3,439B 50.59B 342B 134B 1,720B 135B 132B 5,729B P/E 2026 *
43.8x
P/E 2027 * 27.1x
Enterprise Value 38.43B 200B 33.19B 31.23B 28.38B 53.38B 3,682B 54.17B 366B 144B 1,842B 144B 141B 6,134B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.17x
Free-Float
97.34%
Yield 2026 *
0.5%
Yield 2027 * 0.56%
1 day+6.98%
Current month+11.50%
1 month+11.50%
3 months+12.19%
6 months-4.52%
Current year-15.56%
1 month 34.08
Extreme 34.08
38
Current year 30.88
Extreme 30.88
43.96
1 year 30.88
Extreme 30.88
45
3 years 30.88
Extreme 30.88
56.76
5 years 30.35
Extreme 30.35
56.76
10 years 30.35
Extreme 30.35
56.76
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+6.98%0.00% - - 35.14B
+2.57%-4.29%-38.73%-5.70% 85.07B
+2.48%+3.46%-14.46%-16.45% 35.14B
+0.88%-0.73%+3.41%-17.67% 14.65B
+3.42%+7.21% - - 11.05B
-0.68%+9.60%-3.79%+700.39% 2.53B
-1.92%-4.25%-40.55%-59.61% 1.52B
+0.82%-2.47%+63.06%-2.38% 912M
+0.44%-0.37%-36.10%-21.23% 880M
-0.55%-4.62%+12.09%+6.48% 877M
Average +1.41%-0.19%-6.88%+72.98% 16.96B
Weighted average by Cap. +3.13%-3.29%-26.75%+2.41%

Financials

2026 *2027 *
Net sales 11.09B 57.82B 9.58B 9.01B 8.19B 15.4B 1,063B 15.63B 106B 41.43B 531B 41.63B 40.73B 1,770B 11.77B 61.39B 10.17B 9.57B 8.7B 16.36B 1,128B 16.59B 112B 43.98B 564B 44.2B 43.24B 1,879B
Net income 776M 4.05B 670M 631M 573M 1.08B 74.36B 1.09B 7.4B 2.9B 37.19B 2.91B 2.85B 124B 1.25B 6.52B 1.08B 1.02B 924M 1.74B 120B 1.76B 11.92B 4.67B 59.95B 4.7B 4.59B 200B
Net Debt 2.54B 13.22B 2.19B 2.06B 1.87B 3.52B 243B 3.57B 24.17B 9.47B 121B 9.52B 9.31B 405B 1.43B 7.45B 1.23B 1.16B 1.05B 1.98B 137B 2.01B 13.62B 5.34B 68.45B 5.36B 5.25B 228B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Date Price Change Volume
18/08/26 BRL 38.00 +6.98% 10
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
74.25USD
Average target price
91.40USD
Spread / Average Target
+23.10%

Quarterly revenue - Rate of surprise